These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 11717329)
1. Androgen receptor signaling in androgen-refractory prostate cancer. Grossmann ME; Huang H; Tindall DJ J Natl Cancer Inst; 2001 Nov; 93(22):1687-97. PubMed ID: 11717329 [TBL] [Abstract][Full Text] [Related]
2. Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer. Nguyen MM; Wang Z Minerva Urol Nefrol; 2008 Mar; 60(1):15-29. PubMed ID: 18427432 [TBL] [Abstract][Full Text] [Related]
4. The role of the androgen receptor in the development and progression of prostate cancer. Jenster G Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183 [TBL] [Abstract][Full Text] [Related]
5. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms involved in hormone resistance of prostate cancer]. Cabrespine A; Guy L; Chollet P; Debiton E; Bay JO Bull Cancer; 2004 Oct; 91(10):747-57. PubMed ID: 15556875 [TBL] [Abstract][Full Text] [Related]
7. The role of androgens and the androgen receptor in prostate cancer. Debes JD; Tindall DJ Cancer Lett; 2002 Dec; 187(1-2):1-7. PubMed ID: 12359344 [TBL] [Abstract][Full Text] [Related]
8. Hormone treatment for prostate cancer: current issues and future directions. Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor involvement in the progression of prostate cancer. Suzuki H; Ueda T; Ichikawa T; Ito H Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784 [TBL] [Abstract][Full Text] [Related]
11. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Chatterjee B Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959 [TBL] [Abstract][Full Text] [Related]
12. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. Terry S; Yang X; Chen MW; Vacherot F; Buttyan R J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972 [TBL] [Abstract][Full Text] [Related]
13. Hormones and prostate cancer: what's next? Hsing AW Epidemiol Rev; 2001; 23(1):42-58. PubMed ID: 11588854 [TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of androgen action in prostate cancer. Dehm SM; Tindall DJ J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832 [TBL] [Abstract][Full Text] [Related]
15. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Libertini SJ; Tepper CG; Rodriguez V; Asmuth DM; Kung HJ; Mudryj M Cancer Res; 2007 Oct; 67(19):9001-5. PubMed ID: 17909000 [TBL] [Abstract][Full Text] [Related]
16. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096 [TBL] [Abstract][Full Text] [Related]